Sandra S. Garner

663 total citations
38 papers, 447 citations indexed

About

Sandra S. Garner is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sandra S. Garner has authored 38 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sandra S. Garner's work include Pharmaceutical studies and practices (8 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Respiratory Support and Mechanisms (7 papers). Sandra S. Garner is often cited by papers focused on Pharmaceutical studies and practices (8 papers), Inhalation and Respiratory Drug Delivery (8 papers) and Respiratory Support and Mechanisms (7 papers). Sandra S. Garner collaborates with scholars based in United States, Türkiye and Australia. Sandra S. Garner's co-authors include Donald B. Wiest, David Habib, Toby H. Cox, Jana Bradley, Kelly R. Ragucci, Walter E. Uber, Robert M. Sade, Myla Ebeling, William T. Basco and David J. Annibale and has published in prestigious journals such as PEDIATRICS, Critical Care Medicine and The Journal of Pediatrics.

In The Last Decade

Sandra S. Garner

37 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra S. Garner United States 14 166 123 101 58 52 38 447
Pamela D. Reiter United States 16 94 0.6× 225 1.8× 61 0.6× 19 0.3× 66 1.3× 45 617
Olivier Giannini Switzerland 11 107 0.6× 42 0.3× 94 0.9× 38 0.7× 30 0.6× 31 343
Robert Quercia United States 12 100 0.6× 126 1.0× 33 0.3× 29 0.5× 16 0.3× 31 548
Jaclyn M. LeBlanc United States 13 79 0.5× 39 0.3× 34 0.3× 82 1.4× 102 2.0× 26 492
Glen Brown Canada 16 52 0.3× 66 0.5× 61 0.6× 60 1.0× 32 0.6× 46 706
Διαμάντω Αρέθα Greece 15 116 0.7× 39 0.3× 61 0.6× 35 0.6× 123 2.4× 42 770
Laurie S. Mauro United States 12 90 0.5× 102 0.8× 36 0.4× 14 0.2× 24 0.5× 30 421
Peter A Kendall Australia 10 397 2.4× 37 0.3× 47 0.5× 56 1.0× 32 0.6× 16 665
Charles D. Peterson United States 17 52 0.3× 52 0.4× 89 0.9× 154 2.7× 28 0.5× 37 767
Angela S. Czaja United States 15 131 0.8× 200 1.6× 92 0.9× 15 0.3× 144 2.8× 44 816

Countries citing papers authored by Sandra S. Garner

Since Specialization
Citations

This map shows the geographic impact of Sandra S. Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra S. Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra S. Garner more than expected).

Fields of papers citing papers by Sandra S. Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra S. Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra S. Garner. The network helps show where Sandra S. Garner may publish in the future.

Co-authorship network of co-authors of Sandra S. Garner

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra S. Garner. A scholar is included among the top collaborators of Sandra S. Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra S. Garner. Sandra S. Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Townsend, Danyelle M., et al.. (2024). CYP3A4 drug metabolism considerations in pediatric pharmacotherapy. Medicinal Chemistry Research. 33(12). 2221–2235. 3 indexed citations
2.
Hartley, Christopher, et al.. (2023). Successful Eradication of a Highly Resistant Elizabethkingia anophelis Species in a Premature Neonate With Bacteremia and Meningitis. The Pediatric Infectious Disease Journal. 42(12). e461–e465. 1 indexed citations
3.
Cox, Toby H., et al.. (2023). First hepatitis B vaccine uptake in neonates prior to and during the COVID-19 pandemic. Vaccine. 41(17). 2824–2828. 6 indexed citations
4.
Weeda, Erin R., et al.. (2022). Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma. Respiratory Medicine. 207. 107096–107096.
5.
6.
Basco, William T., et al.. (2015). Evaluating the Potential Severity of Look-Alike, Sound-Alike Drug Substitution Errors in Children. Academic Pediatrics. 16(2). 183–191. 9 indexed citations
7.
Hammond, Drayton A., et al.. (2015). Assessment of mentor involvement with pharmacy students pursuing post-graduate residency training. Currents in Pharmacy Teaching and Learning. 8(1). 18–23. 16 indexed citations
8.
Wiest, Donald B., et al.. (2014). Antenatal Pharmacokinetics and Placental Transfer of N-Acetylcysteine in Chorioamnionitis for Fetal Neuroprotection. The Journal of Pediatrics. 165(4). 672–677.e2. 38 indexed citations
9.
Palmer, David, et al.. (2012). An exploration into the effectiveness of self‐help CBT for mothers with mild to moderate depression and/or anxiety in the London Borough of Bexley. Journal of Children s Services. 7(3). 178–190. 2 indexed citations
10.
Ragucci, Kelly R., et al.. (2010). Survey of Colleges of Pharmacy to Assess Preparation for and Promotion of Residency Training. American Journal of Pharmaceutical Education. 74(3). 43–43. 39 indexed citations
11.
Garner, Sandra S., et al.. (2009). Gabapentin Therapy for Pain and Irritability in a Neurologically Impaired Infant. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(8). 997–1001. 18 indexed citations
12.
Garner, Sandra S., Donald B. Wiest, Charles E. Stevens, & David Habib. (2006). Effect of Heliox on Albuterol Delivery by Metered‐Dose Inhaler in Pediatric In Vitro Models of Mechanical Ventilation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(10). 1396–1402. 11 indexed citations
13.
Garner, Sandra S., et al.. (2002). Albuterol delivery with conventional and synchronous ventilation in a neonatal lung model. Pediatric Critical Care Medicine. 3(1). 52–56. 6 indexed citations
14.
Garner, Sandra S.. (2002). Two administration methods for inhaled salbutamol in intubated patients. Archives of Disease in Childhood. 87(1). 49–53. 5 indexed citations
15.
Garner, Sandra S., Donald B. Wiest, & Jana Bradley. (2000). Albuterol delivery by metered-dose inhaler in a pediatric high-frequency oscillatory ventilation model. Critical Care Medicine. 28(6). 2086–2089. 20 indexed citations
16.
Habib, David, et al.. (1999). Effect of Helium‐Oxygen on Delivery of Albuterol in a Pediatric, Volume‐Cycled, Ventilated Lung Model. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(2). 143–149. 40 indexed citations
17.
Wiest, Donald B., Sandra S. Garner, Walter E. Uber, & Robert M. Sade. (1998). Esmolol for the management of pediatric hypertension after cardiac operations. Journal of Thoracic and Cardiovascular Surgery. 115(4). 890–897. 40 indexed citations
18.
Garner, Sandra S., et al.. (1996). Albuterol delivery by metered-dose inhaler in a mechanically ventilated pediatric lung model. Critical Care Medicine. 24(5). 870–874. 14 indexed citations
19.
Wiest, Donald B., et al.. (1991). Pharmacokinetics of esmolol in children. Clinical Pharmacology & Therapeutics. 49(6). 618–623. 18 indexed citations
20.
Garner, Sandra S. & Donald B. Wiest. (1990). Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system. American Journal of Health-System Pharmacy. 47(3). 604–606. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela D. Reiter Breakdown of academic impact, for papers by Olivier Giannini Breakdown of academic impact, for papers by Robert Quercia Breakdown of academic impact, for papers by Jaclyn M. LeBlanc Breakdown of academic impact, for papers by Glen Brown Breakdown of academic impact, for papers by Διαμάντω Αρέθα Breakdown of academic impact, for papers by Laurie S. Mauro Breakdown of academic impact, for papers by Peter A Kendall Breakdown of academic impact, for papers by Charles D. Peterson Breakdown of academic impact, for papers by Angela S. Czaja
Rankless by CCL
2026